Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives - Schedule of Acquisitions and Cost-Reduction/Productivity Initiatives (Detail) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 11, 2022 |
Oct. 02, 2022 |
Apr. 03, 2022 |
Oct. 03, 2021 |
Oct. 02, 2022 |
Oct. 03, 2021 |
|||||||||||
Restructuring charges/(credits): | ||||||||||||||||
Employee terminations | $ 158 | $ 630 | $ 293 | $ 649 | ||||||||||||
Asset impairments | 17 | 10 | 44 | 7 | ||||||||||||
Exit costs/(credits) | 2 | 3 | 31 | 0 | ||||||||||||
Restructuring charges/(credits) | [1] | 177 | 643 | 368 | 656 | |||||||||||
Transaction costs | [2] | 0 | 0 | 42 | 0 | |||||||||||
Integration costs and other | [3] | 22 | 3 | 170 | 11 | |||||||||||
Restructuring charges and certain acquisition-related costs | 199 | 646 | 580 | 667 | ||||||||||||
Additional depreciation––asset restructuring | [4] | 7 | 27 | 22 | 76 | |||||||||||
Implementation costs | [5] | 150 | 151 | 384 | 316 | |||||||||||
Total costs associated with acquisitions and cost-reduction/productivity initiatives | 357 | 760 | 982 | 1,008 | ||||||||||||
Biopharma [Member] | ||||||||||||||||
Restructuring charges/(credits): | ||||||||||||||||
Restructuring charges/(credits) | 62 | 616 | 108 | 617 | ||||||||||||
Other (income)/deductions––net [Member] | ||||||||||||||||
Restructuring charges/(credits): | ||||||||||||||||
Net periodic benefit costs/(credits) recorded in Other (income)/deductions––net | 0 | (63) | (5) | (51) | ||||||||||||
Cost of sales [Member] | ||||||||||||||||
Restructuring charges/(credits): | ||||||||||||||||
Additional depreciation––asset restructuring | [4] | 7 | 19 | 22 | 53 | |||||||||||
Implementation costs | [5] | 14 | 8 | 40 | 29 | |||||||||||
Selling, informational and administrative expenses [Member] | ||||||||||||||||
Restructuring charges/(credits): | ||||||||||||||||
Additional depreciation––asset restructuring | [4] | 1 | 8 | 1 | 23 | |||||||||||
Implementation costs | [5] | 136 | 142 | 344 | 287 | |||||||||||
Research and Development Expense [Member] | ||||||||||||||||
Restructuring charges/(credits): | ||||||||||||||||
Implementation costs | [5] | $ 0 | $ 0 | $ 0 | $ 1 | |||||||||||
Restructuring Charges And Acquisition-Related Costs [Member] | Arena [Member] | ||||||||||||||||
Restructuring charges/(credits): | ||||||||||||||||
Post closing compensation expense | $ 138 | $ 138 | ||||||||||||||
|